Amgen increases share buyback programme by $5 billion
This article was originally published in Scrip
Amgen's board of directors has authorised an expansion of the company's share buyback programme by $5 billion. It also has $1.2 billion remaining under a previous stock repurchase programme. The company said the move reflected its confidence in its long-term prospects.